Movado Group (NYSE:MOV) Stock, Quote.Headers.trade-ideas

Movado Group

Movado Group Inc designs, develops, sources, markets, and distributes fine watches in the United States and internationally. It operates through the Watch and Accessory Brands and Company Stores segment. The Watch and Accessory Brands segment includes the designing, manufacturing, and distribution of watches and, to a lesser extent, jewelry and other accessories of quality owned brands and licensed brands. Its Company Stores segment includes the company's retail outlet locations in the United States and Canada. It generates maximum revenue from the Watch and Accessory Brands segment. Geographically, it derives the majority of its revenue from its international locations.

MOV, Movado

Earnings

Equities

News

Guidance

Markets

General

Movado reports Q1 earnings beat at 13 cents EPS but misses revenue estimates at $136.669 million, driving shares lower.

Watch Company Movado Aims For H2 Comeback Amid Q1 Revenue Dip: Details

jim-cramer_shutterstock2

&#39;I Don&#39;t Want You To Lose Any Money&#39;: Jim Cramer On This Industrial Stock: &#39;Go Buy GE Vernova&#39;

Movers

Movado Group reports Q4 earnings beat and outpaces revenue expectation. Movado expects FY25 earnings per share of $1.20-$1.30, below the consensus of $2.06. The company expects net sales for the first half of fiscal 2025 to be relatively flat year-over-year.

Why Movado Group Shares Are Falling Today

Movado Group Inc

MOVADO GROUP INC A by Movado Group, Inc.

Movano Inc

Moonriver

Moveix Inc

MOVELLA HOLDINGS INC by Movella Holdings Inc.

Movella Holdings Inc

Movella Holdings Inc Warrants (10/02/2028)

MOVEMENT INDS CORP by MOVEMENT INDS CORP.

Movement Industries Corp

MovieBloc - United States Dollar

Moving iMage Technologies, Inc. Common Stock

Moving iMage Technologies Inc

WIIM

Movado Group shares are trading lower after the company reported worse-than-expected Q2 EPS results and lowered its FY25 guidance.

Movado Group Lowers FY25 Outlook: Sees Sales Of $665.0M-$675.0M Vs. $701.5M Estimate (Prior View: $700.0M-$710.0M); Projects Earnings Per Share Of $0.90-$1.00 Vs. $1.26 Estimate (Prior View: $1.20-$1.30)

Movado Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOV#NYSE">MOV</a>) reported quarterly earnings of $0.16 per share which missed the analyst consensus estimate of $0.19 by 15.79 percent. This is a 57.89 percent decrease over earnings of $0.38 per share from the same period last year. The company reported quarterly sales of $159.31 million which beat the analyst consensus estimate of $150.50 million by 5.86 percent. This is a 0.67 percent decrease over sales of $160.39 million the same period last year.

Earnings Beats

Earnings Misses

Movado Group Q2 EPS $0.16 Misses $0.19 Estimate, Sales $159.31M Beat $150.50M Estimate

Benchmark analyst Michael Legg reiterates Movado Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOV#NYSE">MOV</a>) with a Buy and maintains $41 price target.

Price Target

Reiteration

Analyst Ratings

Benchmark Reiterates Buy on Movado Group, Maintains $41 Price Target

Movado Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOV#NYSE">MOV</a>) shares are trading lower <a target="_blank" href="https://www.benzinga.com/movers" rel="noreferrer noopener">after the company reported first-quarter results.</a>
The company reported quarterly earnings per share of 13 cents, beating the <a target="_blank" href="https://www.benzinga.com/pressreleases/24/05/b39081605/movado-group-inc-announces-first-quarter-fiscal-2025-results" rel="noreferrer noopener">street view of 12 cents</a>.
Quarterly revenues of $136.669 million <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">missed the analyst consensus of $145.200 million.</a>
Net sales decreased 5.7% (decreased 6.1% on a constant dollar basis), owing to declines in wholesale customers&#8217; brick and mortar stores and Movado Company Stores.
Movado generated a gross margin of 55.3% in the quarter under review, as compared to 56.6% in the year-ago period. The decrease in gross margin percentage was primarily the result of unfavorable changes in channel and product mix, along with the decreased leverage of certain fixed costs as a result of lower sales.
The company generated operating income of $3.3 million, compared to $10.9 million in the prior year period.
&#8220;As planned, we will begin to ramp up our marketing investments during the second quarter to support our strategic growth opportunities, including an exciting new Movado campaign that will launch in the fall,&#8221; Efraim Grinberg, Chairman and Chief Executive Officer, stated.
&#8220;We expect our amplified marketing messaging to grow brand awareness and deliver a return to sales growth in the second half of the year,&#8221; Grinberg added.
Dividend: Movado approved a cash dividend of $0.35 per share, which will be paid on June 26 to shareholders of record as of the close of business on June 12.
Outlook: The company continues to expect fiscal 2025 net sales of approximately $700 million &#8211; $710 million versus the $700.8 million estimate and EPS of $1.20 &#8211; $1.30 <a href="https://www.benzinga.com/calendars/guidance">against the consensus of $1.12.</a>
Movado sees gross profit of approximately 55% of net sales, and operating income of approximately $32 million to $35 million.
Price Action: MOV shares are trading lower by 1.61% to $26.33 at last check Thursday.
Read Next: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/05/39045085/analyst-upgrades-duolingo-sees-very-different-user-experience-than-chatgpt" target="_blank" rel="noreferrer noopener">Analyst Upgrades Duolingo, Sees Very Different User Experience Than ChatGPT</a>
Photo by Matthew Bain Via Shutterstock

Fiscal 2025&nbsp;Outlook
The Company continues to expect fiscal 2025 net sales to be in a range of approximately&nbsp;$700 million&nbsp;to&nbsp;$710 million, gross profit of approximately&nbsp;55%&nbsp;of net sales, and operating income in a range of approximately&nbsp;$32 million&nbsp;to&nbsp;$35 million. Assuming no changes to current tax regulations, the Company anticipates an effective tax rate of approximately&nbsp;22%&nbsp;for the fiscal year and earnings in a range of approximately&nbsp;$1.20&nbsp;to&nbsp;$1.30&nbsp;per diluted share.&nbsp;

Movado Group Reiterated FY25 Net Sales of $700.0M-$710.0M Vs $700.8M Est, EPS of $1.20-$1.30 Vs $1.12 Est

Movado Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOV#NYSE">MOV</a>) reported quarterly earnings of $0.13 per share which beat the analyst consensus estimate of $0.12 by 8.33 percent. The company reported quarterly sales of $136.669 million which missed the analyst consensus estimate of $145.200 million by 5.88 percent. This is a 5.68 percent decrease over sales of $144.905 million the same period last year.

Movado Group Q1 2025 GAAP EPS $0.13 Beats $0.12 Estimate, Sales $136.669M Miss $145.200M Estimate

On CNBC's &#8220;Mad Money Lightning Round,&#8221; Jim Cramer said GigaCloud Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GCT#NASDAQ">GCT</a>) is an e-commerce play that he just doesn't know enough about. He needs to do more <a href="https://www.benzinga.com/news/earnings/24/03/37752390/why-gigacloud-technology-shares-are-surging-today">work on that one</a>.
On March 15, GigaCloud Technology reported better-than-expected fourth-quarter FY 2023 earnings and issued 2024 guidance. Revenue rose 94.8% Y/Y to $244.7 million, beating the consensus of $224.2 million, led by higher market demand for large parcel merchandise.
&#8220;It never really does anything. I think its stuff is kind of overpriced, but you do get that yield,&#8221; Cramer said when asked about Movado Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOV#NYSE">MOV</a>). &#8220;I feel it's neither here nor there at that price.&#8221;
On March 26, Movado reported fourth-quarter adjusted earnings per share of 55 cents, beating the analyst consensus of 39 cents. Quarterly revenue of $179.62 million beat the street view of $174.80 million. The company generated a gross margin of 53.9% as compared to 56.2% in the <a href="https://www.benzinga.com/news/earnings/24/03/37936301/why-movado-group-shares-are-falling-today">fourth quarter of fiscal 2023</a>.
When asked about NuScale Power (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMR#NYSE">SMR</a>), Cramer said go buy GE Vernova Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEV#NYSE">GEV</a>). &#8220;I don't want you to lose any money,&#8221; he added.
NuScale Power is scheduled to host a conference call to review first-quarter results on Thursday, May 9. Analysts expect the company to report a quarterly loss at 13 cents per share on revenue of $8.26 million.
Price Action:
<ul>
<li>Movado shares rose 0.4% to settle at $26.30 on Thursday.</li>
<li>GigaCloud Technology shares gained 1.3% to settle at $36.36 during Thursday's session.</li>
<li>NuScale Power shares climbed 7.1% to close at $5.89 on Thursday.</li>
</ul>
Read Next: <a href="https://www.benzinga.com/news/24/04/38430578/top-3-financial-stocks-that-could-sink-your-portfolio-this-quarter">Top 3 Financial Stocks That Could Sink Your Portfolio This Quarter</a>
Image: Shutterstock

'I Don't Want You To Lose Any Money': Jim Cramer On This Industrial Stock: 'Go Buy GE Vernova'

Movado Group Inc.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOV#NYSE">MOV</a>) shares are trading lower in the&nbsp;<a target="_blank" href="https://www.benzinga.com/premarket" rel="noreferrer noopener">morning session on Tuesday</a>.
The company reported fourth-quarter adjusted earnings per share of 55 cents,&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/24/03/b37929434/movado-group-inc-announces-fourth-quarter-and-fiscal-year-2024-results" rel="noreferrer noopener">beating the analyst consensus of 39 cents</a>.
Quarterly revenue of $179.62 million beat the street view of $174.80 million. The company generated a gross margin of 53.9% as compared to 56.2%<a href="https://www.benzinga.com/calendars/earnings" target="_blank" rel="noreferrer noopener"> in the fourth quarter of fiscal 2023.</a>
Movado reported a fourth-quarter adjusted operating income of $13.8 million compared to $26.8 million in the year-ago period.
The company approved the payment on April 23, 2024, of a cash dividend in the amount of $0.35 for each share of the company&#8217;s outstanding common stock.
During the fourth quarter of fiscal 2024, the company repurchased approximately 26,000 shares under its November 23, 2021, share repurchase program.&nbsp;
As of January 31, 2024, the company had $17.9 million remaining available under the share repurchase program.
Outlook:&nbsp;The company expects fiscal 2025 net sales to be in the range of approximately&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">$700 million to $710 million (consensus $689.90 million).</a>
The company expects FY25 gross profit of approximately 55% of net sales and operating income ranging from approximately $32 million to $35 million.
Movado expects FY25 earnings per share of $1.20-$1.30, below the consensus of $2.06.
The company expects net sales for the first half of fiscal 2025 to be relatively flat year-over-year.
According to&nbsp;<a target="_blank" href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" rel="noreferrer noopener">Benzinga Pro</a>, MOV stock has lost over 67% in the past year.&nbsp;
Price Action:&nbsp;MOV shares are trading lower by 2.30% to $25.91 on the last check Tuesday.&nbsp;

The Company expects fiscal 2025 net sales to be in a range of approximately&nbsp;$700 million&nbsp;to&nbsp;$710 million, gross profit of approximately&nbsp;55%&nbsp;of net sales, and operating income in a range of approximately&nbsp;$32 million&nbsp;to&nbsp;$35 million. Assuming no changes to current tax regulations, the Company anticipates an effective tax rate of approximately&nbsp;22%&nbsp;for the fiscal year and earnings in a range of approximately&nbsp;$1.20&nbsp;to&nbsp;$1.30&nbsp;per diluted share.

Movado Group Expects Fiscal 2025 Net Sales To Be In A Range Of $700M-$710M Vs. $689.9M Estimate, Earnings Per Share Of $1.20-$1.30

Movado Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOV#NYSE">MOV</a>) reported quarterly earnings of $0.55 per share which beat the analyst consensus estimate of $0.39 by 41.03 percent. This is a 46.6 percent decrease over earnings of $1.03 per share from the same period last year. The company reported quarterly sales of $179.62 million which beat the analyst consensus estimate of $174.80 million by 2.76 percent. This is a 7.54 percent decrease over sales of $194.27 million the same period last year.

Movado Group Q4 Adj. EPS $0.55 Beats $0.39 Estimate, Sales $179.62M Beat $174.80M Estimate

<h3>Companies Reporting Before The Bell</h3>
&bull; bluebird bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLUE#NASDAQ">BLUE</a>) is likely to report quarterly loss at $0.66 per share on revenue of $16.68 million.
&bull; AIM ImmunoTech (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AIM#AMEX">AIM</a>) is estimated to report earnings for its fourth quarter.
&bull; Elbit Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ESLT#NASDAQ">ESLT</a>) is projected to report quarterly earnings at $1.38 per share on revenue of $1.52 billion.
&bull; GDS Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDS#NASDAQ">GDS</a>) is likely to report quarterly loss at $0.33 per share on revenue of $357.63 million.
&bull; Bragg Gaming Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRAG#NASDAQ">BRAG</a>) is estimated to report quarterly loss at $0.01 per share on revenue of $37.82 million.
&bull; BioLine Rx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLRX#NASDAQ">BLRX</a>) is expected to report earnings for its fourth quarter.
&bull; Zhihu (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZH#NYSE">ZH</a>) is likely to report quarterly loss at $0.04 per share on revenue of $148.11 million.
&bull; DouYu Intl Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOYU#NASDAQ">DOYU</a>) is estimated to report quarterly loss at $0.02 per share on revenue of $170.91 million.
&bull; Waterdrop (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WDH#NYSE">WDH</a>) is estimated to report quarterly earnings at $0.01 per share on revenue of $94.55 million.
&bull; Forza X1 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRZA#NASDAQ">FRZA</a>) is likely to report earnings for its fourth quarter.
&bull; Acumen Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABOS#NASDAQ">ABOS</a>) is likely to report earnings for its fourth quarter.
&bull; Twin Vee PowerCats (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VEEE#NASDAQ">VEEE</a>) is likely to report earnings for its fourth quarter.
&bull; Delcath Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DCTH#NASDAQ">DCTH</a>) is expected to report quarterly loss at $0.51 per share on revenue of $540 thousand.
&bull; Volato Group (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SOAR#AMEX">SOAR</a>) is estimated to report earnings for its fourth quarter.
&bull; Movado Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOV#NYSE">MOV</a>) is likely to report quarterly earnings at $0.39 per share on revenue of $174.80 million.
&bull; Cognition Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGTX#NASDAQ">CGTX</a>) is estimated to report earnings for its fourth quarter.
&bull; McCormick &amp; Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MKC#NYSE">MKC</a>) is expected to report quarterly earnings at $0.58 per share on revenue of $1.56 billion.
&bull; Kaspi.kz (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KSPI#NASDAQ">KSPI</a>) is estimated to report earnings for its first quarter.
&bull; TD Synnex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNX#NYSE">SNX</a>) is likely to report quarterly earnings at $2.84 per share on revenue of $14.36 billion.
<h3>Companies Reporting After The Bell</h3>
&bull; Sidus Space (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIDU#NASDAQ">SIDU</a>) is estimated to report earnings for its fourth quarter.
&bull; Marpai (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRAI#NASDAQ">MRAI</a>) is estimated to report earnings for its fourth quarter.
&bull; NovaBay Pharmaceuticals (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/NBY#AMEX">NBY</a>) is likely to report quarterly loss at $0.30 per share on revenue of $3.40 million.
&bull; Aptose Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APTO#NASDAQ">APTO</a>) is projected to report earnings for its fourth quarter.
&bull; Direct Digital Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DRCT#NASDAQ">DRCT</a>) is likely to report quarterly earnings at $0.26 per share on revenue of $65.95 million.
&bull; US Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/USEG#NASDAQ">USEG</a>) is expected to report quarterly loss at $0.03 per share on revenue of $8.87 million.
&bull; X Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XYF#NYSE">XYF</a>) is likely to report earnings for its fourth quarter.
&bull; Iridex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRIX#NASDAQ">IRIX</a>) is likely to report quarterly loss at $0.05 per share on revenue of $14.90 million.
&bull; iPath Series B Carbon Exchange-Traded Notes (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GRN#NYSE">GRN</a>) is projected to report quarterly loss at $0.01 per share on revenue of $13.40 million.
&bull; Intrusion (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTZ#NASDAQ">INTZ</a>) is likely to report quarterly loss at $0.11 per share on revenue of $1.64 million.
&bull; BioAtla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCAB#NASDAQ">BCAB</a>) is expected to report earnings for its fourth quarter.
&bull; GameStop (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GME#NYSE">GME</a>) is likely to report quarterly earnings at $0.29 per share on revenue of $2.05 billion.
&bull; Forge Global Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FRGE#NYSE">FRGE</a>) is likely to report quarterly loss at $0.10 per share on revenue of $19.57 million.
&bull; Biora Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIOR#NASDAQ">BIOR</a>) is expected to report earnings for its fourth quarter.
&bull; ProSomnus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OSA#NASDAQ">OSA</a>) is expected to report quarterly loss at $0.31 per share on revenue of $7.37 million.
&bull; ATA Creativity Glb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AACG#NASDAQ">AACG</a>) is likely to report earnings for its fourth quarter.
&bull; Noah Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOAH#NYSE">NOAH</a>) is estimated to report earnings for its fourth quarter.
&bull; PAVmed (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAVM#NASDAQ">PAVM</a>) is projected to report quarterly loss at $1.89 per share on revenue of $1.05 million.
&bull; AEye (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIDR#NASDAQ">LIDR</a>) is likely to report quarterly loss at $1.20 per share on revenue of $100 thousand.
&bull; Velo3D (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VLD#NYSE">VLD</a>) is likely to report quarterly loss at $0.08 per share on revenue of $19.50 million.
&bull; Progress Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRGS#NASDAQ">PRGS</a>) is expected to report quarterly earnings at $1.14 per share on revenue of $181.91 million.
&bull; WidePoint (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/WYY#AMEX">WYY</a>) is estimated to report earnings for its fourth quarter.
&bull; LuxUrban Hotels (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUXH#NASDAQ">LUXH</a>) is expected to report quarterly earnings at $0.09 per share on revenue of $34.20 million.
&bull; Oxbridge Re Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OXBR#NASDAQ">OXBR</a>) is expected to report earnings for its fourth quarter.
&bull; Concentrix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNXC#NASDAQ">CNXC</a>) is estimated to report quarterly earnings at $2.58 per share on revenue of $2.38 billion.
&bull; Ouster (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OUST#NYSE">OUST</a>) is likely to report quarterly loss at $0.83 per share on revenue of $24.06 million.
&bull; Ncino (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCNO#NASDAQ">NCNO</a>) is expected to report quarterly earnings at $0.12 per share on revenue of $124.62 million.
&bull; PaySign (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAYS#NASDAQ">PAYS</a>) is projected to report quarterly earnings at $0.02 per share on revenue of $12.62 million.
&bull; Ryvyl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RVYL#NASDAQ">RVYL</a>) is estimated to report quarterly loss at $0.40 per share on revenue of $18.00 million.
This article was generated by Benzinga&#39;s automated content engine and reviewed by an editor.

AACG

ABOS

APTO

BCAB

BIOR

BLRX

BLUE

BRAG

CGTX

CNXC

DCTH

DOYU

DRCT

ESLT

FRGE

FRZA

INTZ

IRIX

KSPI

LIDR

LUXH

MRAI

NCNO

NOAH

OUST

OXBR

PAVM

PAYS

PRGS

RVYL

SIDU

SOAR

USEG

VEEE

Earnings Scheduled For March 26, 2024

Movado Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOV#NYSE">MOV</a>) is set to give its latest quarterly earnings report on Tuesday, 2024-03-26. Here's what investors need to know before the announcement.
Analysts estimate that Movado Group will report an earnings per share (EPS) of $0.39. 
Movado Group bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Historical Earnings Performance</h3>
Last quarter the company beat EPS by $0.03, which was followed by a 0.27% drop in the share price the next day.
Here's a look at Movado Group's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.75</td>
<td>0.34</td>
<td>0.26</td>
<td>0.86</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.78</td>
<td>0.38</td>
<td>0.43</td>
<td>1.03</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-0.0%</td>
<td>-1.0%</td>
<td>2.0%</td>
<td>-2.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1711375256_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Movado Group were trading at $26.57 as of March 22. Over the last 52-week period, shares are down 7.77%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<a href="https://www.benzinga.com/quote/MOV/earnings">To track all earnings releases for Movado Group visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Preview: Movado Group

In a new SEC filing on December 26, it was revealed that DEMARSILIS, Chief Financial Officer at Movado Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOV#NYSE">MOV</a>), executed a significant exercise of company stock options.
What Happened: A Form 4 filing from the <a href="https://www.sec.gov/Archives/edgar/data/0000072573/000095014223003053//Archives/edgar/data/72573/000095014223003053/0000950142-23-003053-index.htm">U.S. Securities and Exchange Commission</a> on Tuesday showed that DEMARSILIS, Chief Financial Officer at Movado Group, a company in the Consumer Discretionary sector, just exercised stock options worth 44,840 shares of MOV stock with an exercise price of $12.42.
Movado Group shares are currently trading down by 0.0%, with a current price of $30.88 as of Wednesday morning. This brings the total value of DEMARSILIS's 44,840 shares to $827,746.
<h3>About Movado Group</h3>
Movado Group Inc designs, develop, sources, markets, and distributes fine watches in the United States and internationally. It operates through the Watch and Accessory Brands and Company Stores segment. The Watch and Accessory Brands segment includes the designing, manufacturing, and distribution of watches of quality owned brands and licensed brands. Its Company Stores segment includes the company's retail outlet locations in the United States and Canada. It generates maximum revenue from the Watch and Accessory Brands segment. Geographically, it derives the majority of revenue from its international location.
<h3>Movado Group: Financial Performance Dissected</h3>
Revenue Challenges: Movado Group's revenue growth over 3 months faced difficulties. As of 31 October, 2023, the company experienced a decline of approximately -11.22%. This indicates a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Consumer Discretionary sector.
Exploring Profitability:
<ul>
<li>
Gross Margin: The company shows a low gross margin of 54.52%, suggesting potential challenges in cost control and profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): Movado Group's EPS is below the industry average. The company faced challenges with a current EPS of 0.78. This suggests a potential decline in earnings.
</li>
</ul>
Debt Management: With a below-average debt-to-equity ratio of 0.19, Movado Group adopts a prudent financial strategy, indicating a balanced approach to debt management.
Market Valuation:
<ul>
<li>
Price to Earnings (P/E) Ratio: With a lower-than-average P/E ratio of 12.21, the stock indicates an attractive valuation, potentially presenting a buying opportunity.
</li>
<li>
Price to Sales (P/S) Ratio: With a lower-than-average P/S ratio of 1.02, the stock presents an attractive valuation, potentially signaling a buying opportunity for investors interested in sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): The company's EV/EBITDA ratio 6.93 is below the industry average, indicating that it may be relatively undervalued compared to peers.
</li>
</ul>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Why Pay Attention to Insider Transactions</h3>
Insightful as they may be, insider transactions should be considered alongside a thorough examination of other investment criteria.
Within the legal framework, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities as per Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are mandated to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
The initiation of a new purchase by a company insider serves as a strong indication that they expect the stock to rise.
However, insider sells may not always signal a bearish view and can be influenced by various factors.
<h3>Deciphering Transaction Codes in Insider Filings</h3>
When analyzing transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> tend to focus on those in the open market, detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase,while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000072573">Check Out The Full List Of Movado Group's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Trades

Trading Ideas

SALLIE DEMARSILIS At Movado Group Executes Options Exercise, Realizing $827K

Shares of Titan Machinery Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/titn#NASDAQ">TITN</a>) moved lower during Thursday&rsquo;s trading following weak quarterly results.
Titan Machinery posted quarterly earnings of $1.32 per share, missing market estimates of $1.53 per share. The company&rsquo;s quarterly sales came in at $694.12 million versus estimates of $727.20 million.
Titan Machinery shares declined 8.1% to $23.41 on Thursday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>Minim Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/minm#NASDAQ">MINM</a>) shares jumped 700% to $7.36 after gaining over 13% on Wednesday.</li>
<li>AgriFORCE Growing Systems Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/agri#NASDAQ">AGRI</a>) gained 174% to $2.47.</li>
<li>Soligenix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sngx#NASDAQ">SNGX</a>) surged 116% to $0.90 after the company announced it received FDA IND clearance for the Phase 2 clinical trial of dusquetide in the treatment of aphthous ulcers of Beh&ccedil;et&#39;s disease.</li>
<li>ImmunoGen, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/imgn#NASDAQ">IMGN</a>) shares jumped 80% to $28.89 after AbbVie announced it will acquire the company in a transaction valued at $31.26 per share in cash.</li>
<li>Smart for Life, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smfl#NASDAQ">SMFL</a>) gained 46% to $2.2221.</li>
<li>Aditxt, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adtx#NASDAQ">ADTX</a>) shares climbed 45% to $5.00.</li>
<li>REX American Resources Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rex#NYSE">REX</a>) gained 30.7% to $48.22 following strong third-quarter results.</li>
<li>Clearmind Medicine Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cmnd#NASDAQ">CMND</a>) rose 24.2% to $5.03 after surging 22% on Wednesday. Clearmind Medicine recently announced results from its weight loss and metabolic disorder program.</li>
<li>Ucommune International Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/uk#NASDAQ">UK</a>) gained 21.8% to $6.58.</li>
<li>Ampio Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ampe#NASDAQ">AMPE</a>) shares surged 21% to $2.3750 after gaining over 3% on Wednesday.</li>
<li>Reborn Coffee, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rebn#NASDAQ">REBN</a>) gained 19.5% to $0.6216. Reborn Coffee announced conversion of $1 million of outstanding debt into common equity.</li>
<li>Zuora, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zuo#NASDAQ">ZUO</a>) gained 19.5% to $9.98 after the company reported better-than-expected third-quarter financial results and issued guidance.</li>
<li>SpringWorks Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/swtx#NASDAQ">SWTX</a>) climbed 18.3% to $31.75.</li>
<li>Jeffs&#39; Brands Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jfbr#NASDAQ">JFBR</a>) gained 17% to $3.65.</li>
<li>The InterGroup Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/intg#NASDAQ">INTG</a>) rose 13.7% to $25.50.</li>
<li>Victoria&#39;s Secret &amp; Co. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vsco#NYSE">VSCO</a>) climbed 13.6% to $26.80 following third-quarter results.</li>
<li>VinFast Auto Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vfs#NASDAQ">VFS</a>) gained 11.7% to $8.44 after gaining around 8% on Wednesday.</li>
<li>Farfetch Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ftch#NYSE">FTCH</a>) rose 11.2% to $1.0842.</li>
<li>Salesforce, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/crm#NYSE">CRM</a>) shares gained 8.4% to $249.69 after the company reported third-quarter financial results and issued FY24 guidance above estimates.</li>
<li>Oatly Group AB (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/otly#NASDAQ">OTLY</a>) gained 7.5% to $1.0750.</li>
<li>Snowflake Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/snow#NYSE">SNOW</a>) climbed 7.1% to $187.76 after the company reported better-than-expected third-quarter financial results and issued guidance.</li>
<li>Nutanix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ntnx#NASDAQ">NTNX</a>) rose 5% to $43.61 after the company reported better-than-expected first-quarter financial results and raised FY24 revenue guidance.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Vivos Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vvos#NASDAQ">VVOS</a>) shares fell 40.7% to $24.30. Vivos Therapeutics shares jumped around 832% on Wednesday after the company announced it received FDA 510(k) clearance for treating severe obstructive sleep apnea in adults using the Vivos&#39; removable CARE oral appliances.</li>
<li>RedHill Biopharma Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rdhl#NASDAQ">RDHL</a>) fell 35.6% to $1.8499 after gaining 26% on Wednesday. On Monday, Redhill Biopharma announced that the FDA had granted five years&#39; market exclusivity for its drug, Talicia, on top of three years&#39; exclusivity granted for the approval of Talicia.</li>
<li>POET Technologies Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/poet#NASDAQ">POET</a>) fell 31.4% to $0.7603 after the company reported pricing of $1.4 million underwritten public offering of common shares and warrants.</li>
<li>Elevai Labs, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/elab#NASDAQ">ELAB</a>) fell 28% to $2.54.</li>
<li>XORTX Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xrtx#NASDAQ">XRTX</a>) fell 26.8% to $2.2226.</li>
<li>PROOF Acquisition Corp I (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/paci#NASDAQ">PACI</a>) declined 25% to $24.00.</li>
<li>Lizhi Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lizi#NASDAQ">LIZI</a>) fell 21.5% to $2.9750 following third-quarter results.</li>
<li>Gyre Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gyre#NASDAQ">GYRE</a>) declined 14.6% to $22.45.</li>
<li>Carbon Revolution Public Limited Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crev#NASDAQ">CREV</a>) fell 14.3% to $33.00.</li>
<li>Pure Storage, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pstg#NYSE">PSTG</a>) fell 14.2% to $32.54 after the company reported worse-than-expected third-quarter revenue results and issued FY24 revenue guidance below estimates.</li>
<li>Nvni Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvni#NASDAQ">NVNI</a>) shares fell 12.2% to $2.03 after gaining over 5% on Wednesday.</li>
<li>Arrowhead Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arwr#NASDAQ">ARWR</a>) fell 11.8% to $25.55 following FY23 results.</li>
<li>Weibo Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wb#NASDAQ">WB</a>) declined 11.5% to $10.02 after the company announced a proposed offering of $300 million convertible senior notes and a proposed offering of ADSs in connection with the Delta Placement of Borrowed ADSs.</li>
<li>BRP Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dooo#NASDAQ">DOOO</a>) fell 10.6% to $62.48 following third-quarter results.</li>
<li>Movado Group, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mov#NYSE">MOV</a>) fell 9.4% to $26.25 following weak sales.</li>
<li>Safe and Green Development Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sgd#NASDAQ">SGD</a>) fell 9.4% to $2.40 after dipping 14% on Wednesday.</li>
<li>Frontline plc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fro#NYSE">FRO</a>) shares fell 6.7% to $19.77 following downbeat third-quarter earnings.</li>
<li>Cracker Barrel Old Country Store, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cbrl#NASDAQ">CBRL</a>) declined 6.5% to $70.21 following weak results.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/earnings/23/11/36016689/how-to-make-500-a-month-with-pfizer-stock"> How To Make $500 A Month With Pfizer Stock</a>

Penny Stocks

Small Cap

Intraday Update

ADTX

AGRI

AMPE

ARWR

CBRL

CMND

CREV

DOOO

ELAB

FTCH

GYRE

IMGN

INTG

JFBR

LIZI

MINM

NTNX

NVNI

OTLY

PACI

POET

PSTG

RDHL

REBN

SMFL

SNGX

SNOW

SWTX

TITN

VSCO

VVOS

XRTX

Why Titan Machinery Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Movado shares are trading lower after the company reported mixed Q3 financial results and cut FY24 EPS and net sales guidance.

Movado Cuts FY24 Net Sales Guidance From $690M-$700M To $665M-$675M, EPS Outlook From $2.15-$2.25 To $1.85-$2.00

Warning: MOV is at high risk of cutting its dividend

Movado Q2 Earnings Preview

Movado reports mixed Q2 results; lowers full-year outlook

Movado declares $0.35 dividend

Movado Group, Inc. (MOV) Q2 2025 Earnings Call Transcript

50 stocks that may see selling pressure as investors begin looking to book tax losses

Movado: Dividend Under Pressure Unless Increaed Investment Spend Can Spur Growth

Movado Q2: Higher Marketing Spend Shows Little Returns So Far

Warning: MOV is at high risk of performing badly

Consumer stocks buoyed by improving sentiment

APTV

ARCH

BIIB

BRLT

BYON

CALX

CHWY

DVAX

ENOV

ETSY

GTLS

ICHR

MOVAA

MRTN

NEOG

NVEE

PENN

PLAB

PRGO

PTEN

REAL

RGEN

ROCK

SMPL

TALO

XNCR

XPEL

Press Releases

Movado Group, Inc. to Present at the 26th Annual ICR Conference

Movado Group, Inc. Announces Date of Conference Call and Webcast for Fourth Quarter and Fiscal Year 2024 Results

Movado Group, Inc. Announces Fourth Quarter and Fiscal Year 2024 Results

Movado Group Announces Appointment of Debbie Forman-Pavan as President of North America Sales

MVMT, a Movado Group, Inc. Brand, Ramps Up Partnership with World Champion Motocross Racer Jett Lawrence

Movado Group, Inc. Announces Date of Conference Call and Webcast for First Quarter Fiscal Year 2025 Results

Movado Group, Inc. Announces First Quarter Fiscal 2025 Results

Movado Group, Inc. Announces Date of Conference Call and Webcast for Second Quarter Fiscal Year 2025 Results

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Movado Group

Movado Group (MOV) Forecast

Movado Group (NYSE:MOV) Stock, Quote.Headers.trade-ideas